Clinical Trial Update: An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial updates for BMS-986165 in Japanese participants with moderate-to-severe psoriasis have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BMS-986165

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2022-11-02